{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:46:46Z","timestamp":1754110006276},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T00:00:00Z","timestamp":1136937600000},"content-version":"vor","delay-in-days":6038,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biopharm &amp; Drug Disp"],"published-print":{"date-parts":[[1989,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diflunisal, a lipophilic salicylate, is absorbed more slowly in healthy volunteers than aspirin. In this paper we report on attempts to influence diflunisal absorption by buffering the gastric milieu. Sodium bicarbonate given together and 30 min after diflunisal tablets significantly (<jats:italic>p<\/jats:italic> &lt; 0\u00b705) shortened the time to reach peak plasma concentration (<jats:italic>t<\/jats:italic><jats:sub>max<\/jats:sub> &gt; 15 per cent), raised maximum plasma concentration slightly (<jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub> 6 per cent) and increased the area under the plasma concentration\u2010time curve (AUC &gt; 8 per cent). Other pharmacokinetic parameters, including terminal half\u2010life and renal elimination of the compound, were not considerably influenced. These findings indicate that the absorption of diflunisal was enhanced by increased gastric pH, presumably a result of an increased solubility of diflunisal in the stomach together with faster transport into the small intestine.<\/jats:p><jats:p>In one volunteer, after intravenous administration diflunisal plasma concentrations declined in a triphasic manner with a terminal half\u2010life of 12\u00b78 h. The volume of distribution was approximately 10 per cent of body weight. Based on the ratio of AUC after equivalent i.v. and oral diflunisal doses, the absolute bioavailability was 89\u00b75 per cent.<\/jats:p>","DOI":"10.1002\/bdd.2510100405","type":"journal-article","created":{"date-parts":[[2006,10,14]],"date-time":"2006-10-14T11:48:55Z","timestamp":1160826535000},"page":"377-387","source":"Crossref","is-referenced-by-count":5,"title":["Buffering the stomach content enhances the absorption of diflunisal in man"],"prefix":"10.1002","volume":"10","author":[{"given":"Bernd","family":"Nuernberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Brune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,11]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"R4","volume":"325","author":"Nuernberg B.","year":"1984","journal-title":"Naunyn\u2010Schmied. Arch. Pharmacol."},{"key":"e_1_2_1_3_2","unstructured":"T.Baum MD Thesis University of Hanover FRG 1985."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1977.tb04508.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/phar.1983.3.2p2.9","volume":"3","author":"Davies R. O.","year":"1983","journal-title":"Pharmacotherapy"},{"key":"e_1_2_1_6_2","first-page":"763","volume":"47","author":"Nuernberg B.","year":"1985","journal-title":"Pharm. Ind."},{"key":"e_1_2_1_7_2","unstructured":"B.Nuernberg PhD Thesis University of Erlangen\u2010Nuernberg FRG 1986."},{"key":"e_1_2_1_8_2","unstructured":"W.Oechslein PhD Thesis University of Erlangen\u2010Nuernberg 1986."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1047994"},{"key":"e_1_2_1_10_2","first-page":"192","volume-title":"Pharmacokinetics During Drug Development: Data Analysis and Evaluation Techniques","author":"Heinzel G.","year":"1982"},{"key":"e_1_2_1_11_2","first-page":"147","volume":"29","author":"Steinijans V. W.","year":"1983","journal-title":"APT"},{"key":"e_1_2_1_12_2","first-page":"2534","volume":"131","author":"Blume H.","year":"1986","journal-title":"Pharm Ztg"},{"key":"e_1_2_1_13_2","first-page":"15","volume-title":"Profile of a Modern Analgesic Proceedings of an International Symposium","author":"Brune K.","year":"1982"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb01734.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cpt196344476","volume":"4","author":"Leonards J. R.","year":"1962","journal-title":"Clin. Pharmacol Ther."},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600700308"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","unstructured":"J. H.Proost G. W.van ImhoffandH.Wesseling Pharmaceutisch Weekblad Scientific edition 5 22(1983).","DOI":"10.1007\/BF01959647"}],"container-title":["Biopharmaceutics &amp; Drug Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdd.2510100405","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdd.2510100405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T08:17:42Z","timestamp":1697962662000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdd.2510100405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["10.1002\/bdd.2510100405"],"URL":"https:\/\/doi.org\/10.1002\/bdd.2510100405","archive":["Portico"],"relation":{},"ISSN":["0142-2782","1099-081X"],"issn-type":[{"value":"0142-2782","type":"print"},{"value":"1099-081X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}